You are here

  • Home
  • Archive
  • Volume 82, Issue 5
  • Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’

Article info

Article menu

This article has a Reply. Please see:

Download PDFPDF
Correspondence
Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’

Authors

  • Maria De Santis Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano, Lombardia, Italy PubMed articlesGoogle scholar articles
  • Antonio Voza Emergency Department, IRCCS Humanitas Research Hospital, Rozzano, Lombardia, Italy PubMed articlesGoogle scholar articles
  • Victor Savevski Artificial Intelligence Research, IRCCS Humanitas Research Hospital, Rozzano, Lombardia, Italy PubMed articlesGoogle scholar articles
  • Salvatore Badalamenti Nephrology, IRCCS Humanitas Research Hospital, Rozzano, Lombardia, Italy PubMed articlesGoogle scholar articles
  • Maurizio Cecconi Anesthesiology and Intensive Care, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy PubMed articlesGoogle scholar articles
  • Alberto Mantovani Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy Department of Immunology and Inflammation, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy The William Harvey Research Institute, Queen Mary University of London, London, UK PubMed articlesGoogle scholar articles
  • Carlo Selmi Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano, Lombardia, Italy Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Carlo Selmi, Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan, Italy; carlo.selmi{at}hunimed.eu
View Full Text

Citation

De Santis M, Voza A, Savevski V, et al
Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’
Annals of the Rheumatic Diseases 2023;82:e111.

Publication history

  • Received February 2, 2021
  • Accepted February 3, 2021
  • First published February 16, 2021.
Online issue publication 
April 12, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage